Cargando…
Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846928/ http://dx.doi.org/10.1186/1750-1326-8-S1-O17 |
| _version_ | 1782293514315366400 |
|---|---|
| author | Hering, Heike Graham, Danielle Ousson, Solenne Neny, Maud Gray, Audrey Giacomozzi, Brandy Joyce, John Dutt, Vikram Busch, Michael Cameron, Andrew Liu-Bujalski, Leslie Yu, Henry Tian, Hui Shearman, Mark Quattropani, Anna Permanne, Bruno Wiessner, Christoph Beher, Dirk |
| author_facet | Hering, Heike Graham, Danielle Ousson, Solenne Neny, Maud Gray, Audrey Giacomozzi, Brandy Joyce, John Dutt, Vikram Busch, Michael Cameron, Andrew Liu-Bujalski, Leslie Yu, Henry Tian, Hui Shearman, Mark Quattropani, Anna Permanne, Bruno Wiessner, Christoph Beher, Dirk |
| author_sort | Hering, Heike |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3846928 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38469282013-12-09 Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies Hering, Heike Graham, Danielle Ousson, Solenne Neny, Maud Gray, Audrey Giacomozzi, Brandy Joyce, John Dutt, Vikram Busch, Michael Cameron, Andrew Liu-Bujalski, Leslie Yu, Henry Tian, Hui Shearman, Mark Quattropani, Anna Permanne, Bruno Wiessner, Christoph Beher, Dirk Mol Neurodegener Oral Presentation BioMed Central 2013-09-13 /pmc/articles/PMC3846928/ http://dx.doi.org/10.1186/1750-1326-8-S1-O17 Text en Copyright © 2013 Hering et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Hering, Heike Graham, Danielle Ousson, Solenne Neny, Maud Gray, Audrey Giacomozzi, Brandy Joyce, John Dutt, Vikram Busch, Michael Cameron, Andrew Liu-Bujalski, Leslie Yu, Henry Tian, Hui Shearman, Mark Quattropani, Anna Permanne, Bruno Wiessner, Christoph Beher, Dirk Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title | Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title_full | Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title_fullStr | Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title_full_unstemmed | Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title_short | Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies |
| title_sort | novel non-carbohydrate o-glcnacase inhibitors with cns drug properties as potential treatment for alzheimer’s disease and tauopathies |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846928/ http://dx.doi.org/10.1186/1750-1326-8-S1-O17 |
| work_keys_str_mv | AT heringheike novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT grahamdanielle novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT oussonsolenne novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT nenymaud novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT grayaudrey novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT giacomozzibrandy novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT joycejohn novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT duttvikram novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT buschmichael novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT cameronandrew novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT liubujalskileslie novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT yuhenry novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT tianhui novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT shearmanmark novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT quattropanianna novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT permannebruno novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT wiessnerchristoph novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies AT beherdirk novelnoncarbohydrateoglcnacaseinhibitorswithcnsdrugpropertiesaspotentialtreatmentforalzheimersdiseaseandtauopathies |